Try our beta test site

PROMUS™ Element™ Everolimus-Eluting Coronary Stent System European Post-Approval Surveillance Study (PE-Prove)

This study has been completed.
Sponsor:
Collaborators:
Pharmaceutical Research Associates
Medidata Solutions
Information provided by (Responsible Party):
Boston Scientific Corporation
ClinicalTrials.gov Identifier:
NCT01148329
First received: June 21, 2010
Last updated: February 1, 2017
Last verified: February 2017